Alternate-Day Buprenorphine Administration. Phase VI - 7

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1999
The purpose of this study is to determine if four times a subject\'s daily maintenance dose will hold for 96 hours without changes in agonist and antagonist effects.
Epistemonikos ID: 0e6f6a73c0ea858278226b38cd89a582e1a60157
First added on: May 03, 2024